Global Mesalazine Market Insights, Forecast to 2025

Publisher Name :
Date: 28-Oct-2019
No. of pages: 114
Inquire Before Buying

Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

In 2018, the global Mesalazine market is lead by Europe. India is the second-largest region-wise market.

As for the consumption, Europe is the largest consumer, who owned 43.76% share in global consumption market in 2018, consumption volume was 1240.5 MT. The follower is India, with the consumption volume of 519.0 K MT in 2018, accounting for 18.31% sales share in 2018.

Syntese A/S was the largest manufacturer in 2018, with a market share of 23%. Other top 5 manufacturers were Divis Laboratories, Cambrex Corporation, Ipca Laboratories and PharmaZell, with total market share of 52%.

The global Mesalazine market is valued at 125 million US$ in 2018 and will reach 172 million US$ by the end of 2025, growing at a CAGR of 0.042 during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mesalazine market based on company, product type, end user and key regions.

This report studies the global market size of Mesalazine in key regions like North America, Europe, China and India, focuses on the consumption of Mesalazine in these regions.

This research report categorizes the global Mesalazine market by top players/brands, region, type and end user. This report also studies the global Mesalazine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Syntese A/S

Divis Laboratories

Cambrex Corporation

Ipca Laboratories

PharmaZell

Lasa Loboratory

Erregierre SpA

Corden Pharma Bergamo

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalazine market size by Type

Purity ? 97 %

Purity ? 98 %

Purity ? 99 %

Purity?98% occupied the largest sales share of 60.32% in 2018, consumption volume was 1346.6 MT. Purity?99% growth fastest in the forecast period with a CAGR of 4.46% from 2019 to 2025.

Mesalazine market size by Applications

Mesalazine Tablets

Mesalazine Capsules

Others

In 2018, the consumption volume of Mesalazine Tablets was 1456.0 MT, accounting for 51.36% of global share. And it excepted to reach 1811.9 MT in 2025, with the CAGR of 3.41% from 2019 to 2025, slightly lower than global market growth.

Market size by Region

North America

United States

Canada

Mexico

Europe

Germany

France

UK

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Central & South America

Brazil

Middle East & Africa

Turkey

GCC Countries

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Mesalazine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Mesalazine market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Mesalazine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Mesalazine submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Mesalazine are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Mesalazine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Mesalazine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Mesalazine Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Mesalazine Market Size Growth Rate by Type
1.4.2 Purity = 97 %
1.4.3 Purity = 98 %
1.4.4 Purity = 99 %
1.5 Market by Application
1.5.1 Global Mesalazine Market Size Growth Rate by Application
1.5.2 Mesalazine Tablets
1.5.3 Mesalazine Capsules
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Mesalazine Market Size
2.1.1 Global Mesalazine Revenue 2014-2025
2.1.2 Global Mesalazine Sales 2014-2025
2.2 Mesalazine Growth Rate by Regions
2.2.1 Global Mesalazine Sales by Regions
2.2.2 Global Mesalazine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Mesalazine Sales by Manufacturers
3.1.1 Mesalazine Sales by Manufacturers
3.1.2 Mesalazine Sales Market Share by Manufacturers
3.2 Mesalazine Revenue by Manufacturers
3.2.1 Mesalazine Revenue by Manufacturers (2014-2019)
3.2.2 Mesalazine Revenue Share by Manufacturers (2014-2019)
3.3 Mesalazine Price by Manufacturers
3.4 Mesalazine Manufacturing Base Distribution, Product Types
3.4.1 Mesalazine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mesalazine Product Type
3.4.3 Date of International Manufacturers Enter into Mesalazine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Mesalazine Sales by Type
4.2 Global Mesalazine Revenue by Type
4.3 Mesalazine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Mesalazine Breakdown Data by Application
6 North America
6.1 North America Mesalazine by Country
6.1.1 North America Mesalazine Sales by Country
6.1.2 North America Mesalazine Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Mesalazine by Type
6.3 North America Mesalazine by Application
7 Europe
7.1 Europe Mesalazine by Country
7.1.1 Europe Mesalazine Sales by Country
7.1.2 Europe Mesalazine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mesalazine by Type
7.3 Europe Mesalazine by Application
8 Asia Pacific
8.1 Asia Pacific Mesalazine by Region
8.1.1 Asia Pacific Mesalazine Sales by Region
8.1.2 Asia Pacific Mesalazine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Mesalazine by Type
8.3 Asia Pacific Mesalazine by Application
9 Central & South America
9.1 Central & South America Mesalazine by Country
9.1.1 Central & South America Mesalazine Sales by Country
9.1.2 Central & South America Mesalazine Revenue by Country
9.1.3 Brazil
9.2 Central & South America Mesalazine by Type
9.3 Central & South America Mesalazine by Application
10 Middle East and Africa
10.1 Middle East and Africa Mesalazine by Country
10.1.1 Middle East and Africa Mesalazine Sales by Country
10.1.2 Middle East and Africa Mesalazine Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Mesalazine by Type
10.3 Middle East and Africa Mesalazine by Application
11 Company Profiles
11.1 Syntese A/S
11.1.1 Syntese A/S Company Details
11.1.2 Company Business Overview
11.1.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Syntese A/S Mesalazine Products Offered
11.1.5 Syntese A/S Recent Development
11.2 Divis Laboratories
11.2.1 Divis Laboratories Company Details
11.2.2 Company Business Overview
11.2.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Divis Laboratories Mesalazine Products Offered
11.2.5 Divis Laboratories Recent Development
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Company Details
11.3.2 Company Business Overview
11.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cambrex Corporation Mesalazine Products Offered
11.3.5 Cambrex Corporation Recent Development
11.4 Ipca Laboratories
11.4.1 Ipca Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Ipca Laboratories Mesalazine Products Offered
11.4.5 Ipca Laboratories Recent Development
11.5 PharmaZell
11.5.1 PharmaZell Company Details
11.5.2 Company Business Overview
11.5.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 PharmaZell Mesalazine Products Offered
11.5.5 PharmaZell Recent Development
11.6 Lasa Loboratory
11.6.1 Lasa Loboratory Company Details
11.6.2 Company Business Overview
11.6.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Lasa Loboratory Mesalazine Products Offered
11.6.5 Lasa Loboratory Recent Development
11.7 Erregierre SpA
11.7.1 Erregierre SpA Company Details
11.7.2 Company Business Overview
11.7.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Erregierre SpA Mesalazine Products Offered
11.7.5 Erregierre SpA Recent Development
11.8 Corden Pharma Bergamo
11.8.1 Corden Pharma Bergamo Company Details
11.8.2 Company Business Overview
11.8.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Corden Pharma Bergamo Mesalazine Products Offered
11.8.5 Corden Pharma Bergamo Recent Development
11.9 CTX Lifescience
11.9.1 CTX Lifescience Company Details
11.9.2 Company Business Overview
11.9.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 CTX Lifescience Mesalazine Products Offered
11.9.5 CTX Lifescience Recent Development
11.10 Ishita Active Pharma Ingredients
11.10.1 Ishita Active Pharma Ingredients Company Details
11.10.2 Company Business Overview
11.10.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Ishita Active Pharma Ingredients Mesalazine Products Offered
11.10.5 Ishita Active Pharma Ingredients Recent Development
11.11 YC Biotech (Jiangsu)
11.12 Xinxiang Tianfeng Fine Chemical
12 Future Forecast
12.1 Mesalazine Market Forecast by Regions
12.1.1 Global Mesalazine Sales Forecast by Regions 2019-2025
12.1.2 Global Mesalazine Revenue Forecast by Regions 2019-2025
12.2 Mesalazine Market Forecast by Type
12.2.1 Global Mesalazine Sales Forecast by Type 2019-2025
12.2.2 Global Mesalazine Revenue Forecast by Type 2019-2025
12.3 Mesalazine Market Forecast by Application
12.4 North America Mesalazine Forecast
12.5 Europe Mesalazine Forecast
12.6 Asia Pacific Mesalazine Forecast
12.7 Central & South America Mesalazine Forecast
12.8 Middle East and Africa Mesalazine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mesalazine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Mesalazine Product Picture
Table Mesalazine Market Segments
Table Key Manufacturers Mesalazine Covered
Table Global Mesalazine Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Mesalazine Sales Market Share by Type in 2018 & 2025
Figure Purity = 97 % Product Picture
Table Major Manufacturers of Purity = 97 %
Figure Purity = 98 % Product Picture
Table Major Manufacturers of Purity = 98 %
Figure Purity = 99 % Product Picture
Table Major Manufacturers of Purity = 99 %
Table Global Mesalazine Market Size Growth Rate by Application 2019-2025 (MT)
Figure Global Mesalazine 4900 Sales Market Share by Application in 2018
Figure Mesalazine Tablets
Figure Mesalazine Capsules
Figure Others
Figure Mesalazine Report Years Considered
Figure Global Mesalazine Market Size 2014-2025 (Million US$)
Figure Global Mesalazine Sales 2014-2025 (MT)
Table Global Mesalazine Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Mesalazine Sales by Regions 2014-2019 (MT)
Table Global Mesalazine Sales Market Share by Regions 2014-2019
Figure Global Mesalazine Sales Market Share by Regions 2014-2019
Figure 2018 Global Mesalazine Sales Market Share by Regions
Table Global Mesalazine Revenue by Regions 2014-2019 (Million US$)
Table Global Mesalazine Revenue Market Share by Regions 2014-2019
Figure Global Mesalazine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Mesalazine Revenue Market Share by Regions
Table Global Mesalazine Sales by Manufacturers (2014-2019) (MT)
Table Global Mesalazine Sales Share by Manufacturers (2014-2019)
Figure Global Mesalazine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Mesalazine Revenue by Manufacturers (2014-2019) (Million USD)
Table Mesalazine Revenue Share by Manufacturers (2014-2019)
Figure Mesalazine Value Share by Manufacturers in 2018
Table Key Manufacturers Mesalazine Price (2014-2019) (USD/MT)
Table Mesalazine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Mesalazine Product Type
Table Date of International Manufacturers Enter into Mesalazine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Mesalazine Sales by Type (2014-2019) (MT)
Table Global Mesalazine Sales Share by Type (2014-2019)
Figure Global Mesalazine Sales Market Share by Type (2014-2019)
Figure Global Mesalazine Sales Market Share by Type in 2018
Table Global Mesalazine Revenue by Type (2014-2019) (Million US$)
Table Global Mesalazine Revenue Share by Type (2014-2019)
Figure Global Mesalazine Revenue Market Share by Type (2014-2019)
Figure Global Mesalazine Revenue Market Share by Type in 2018
Table Mesalazine Price by Type 2014-2019 (USD/MT)
Table Global Mesalazine Sales by Application (2014-2019) (MT)
Table Global Mesalazine Sales Share by Application (2014-2019)
Figure Global Sales Mesalazine Market Share by Application (2014-2019)
Figure Global Sales Mesalazine Market Share by Application in 2018
Figure North America Mesalazine Sales Growth Rate 2014-2019 (MT)
Figure North America Mesalazine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Mesalazine Sales by Country (2014-2019) (MT)
Table North America Mesalazine Sales Market Share by Country (2014-2019)
Figure 2018 North America Mesalazine Sales Market Share by Country
Table North America Mesalazine Revenue by Country (2014-2019) (Million US$)
Table North America Mesalazine Revenue Market Share by Country (2014-2019)
Figure 2018 North America Mesalazine Revenue Market Share by Country
Figure United States Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure United States Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Canada Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Mexico Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Mesalazine Sales by Type (2014-2019) (MT)
Table North America Mesalazine Sales Market Share by Type (2014-2019)
Figure 2018 North America Mesalazine Market Share by Type
Table North America Mesalazine Sales by Application (2014-2019) (MT)
Table North America Mesalazine Sales Market Share by Application (2014-2019)
Figure 2018 North America Mesalazine Market Share by Application
Figure Europe Mesalazine Sales Growth Rate 2014-2019 (MT)
Figure Europe Mesalazine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Mesalazine Sales by Country (2014-2019) (MT)
Table Europe Mesalazine Sales Market Share by Country (2014-2019)
Figure 2018 Europe Mesalazine Sales Market Share by Country
Table Europe Mesalazine Revenue by Country (2014-2019) (Million US$)
Table Europe Mesalazine Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Mesalazine Revenue Market Share by Country
Figure Germany Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Germany Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure France Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure UK Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Italy Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Russia Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Mesalazine Sales by Type (2014-2019) (MT)
Table Europe Mesalazine Sales Market Share by Type (2014-2019)
Figure 2018 Europe Mesalazine Market Share by Type
Table Europe Mesalazine Sales by Application (2014-2019) (MT)
Table Europe Mesalazine Sales Market Share by Application (2014-2019)
Figure 2018 Europe Mesalazine Market Share by Application
Figure Asia Pacific Mesalazine Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Mesalazine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Mesalazine Sales by Region (2014-2019) (MT)
Table Asia Pacific Mesalazine Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Mesalazine Sales Market Share by Region
Table Asia Pacific Mesalazine Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Mesalazine Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Mesalazine Revenue Market Share by Country
Figure China Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure China Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Japan Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure South Korea Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure India Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Australia Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Thailand Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Philippines Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Mesalazine Sales by Type (2014-2019) (MT)
Table Asia Pacific Mesalazine Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Mesalazine Market Share by Type
Table Asia Pacific Mesalazine Sales by Application (2014-2019) (MT)
Table Asia Pacific Mesalazine Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Mesalazine Market Share by Application
Figure Central & South America Mesalazine Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Mesalazine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Mesalazine Sales by Country (2014-2019) (MT)
Table Central & South America Mesalazine Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Mesalazine Sales Market Share by Country
Table Central & South America Mesalazine Revenue by Country (2014-2019) (Million US$)
Table Central & South America Mesalazine Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Mesalazine Revenue Market Share by Country
Figure Brazil Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Brazil Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Mesalazine Sales by Type (2014-2019) (MT)
Table Central & South America Mesalazine Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Mesalazine Market Share by Type
Table Central & South America Mesalazine Sales by Application (2014-2019) (MT)
Table Central & South America Mesalazine Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Mesalazine Market Share by Application
Figure Middle East and Africa Mesalazine Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Mesalazine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Mesalazine Sales by Country (2014-2019) (MT)
Table Middle East and Africa Mesalazine Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Mesalazine Sales Market Share by Country
Table Middle East and Africa Mesalazine Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Mesalazine Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Mesalazine Revenue Market Share by Country
Figure Turkey Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Turkey Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure Egypt Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Mesalazine Sales Growth Rate (2014-2019) (MT)
Figure South Africa Mesalazine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Mesalazine Sales by Type (2014-2019) (MT)
Table Middle East and Africa Mesalazine Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Mesalazine Market Share by Type
Table Middle East and Africa Mesalazine Sales by Application (2014-2019) (MT)
Table Middle East and Africa Mesalazine Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Mesalazine Market Share by Application
Table Syntese A/S Company Details
Table Syntese A/S Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Syntese A/S Recent Development
Table Divis Laboratories Company Details
Table Divis Laboratories Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Divis Laboratories Recent Development
Table Cambrex Corporation Company Details
Table Cambrex Corporation Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Cambrex Corporation Recent Development
Table Ipca Laboratories Company Details
Table Ipca Laboratories Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Ipca Laboratories Recent Development
Table PharmaZell Company Details
Table PharmaZell Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table PharmaZell Recent Development
Table Lasa Loboratory Company Details
Table Lasa Loboratory Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Lasa Loboratory Recent Development
Table Erregierre SpA Company Details
Table Erregierre SpA Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Erregierre SpA Recent Development
Table Corden Pharma Bergamo Company Details
Table Corden Pharma Bergamo Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Corden Pharma Bergamo Recent Development
Table CTX Lifescience Company Details
Table CTX Lifescience Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table CTX Lifescience Recent Development
Table Ishita Active Pharma Ingredients Company Details
Table Ishita Active Pharma Ingredients Mesalazine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Ishita Active Pharma Ingredients Recent Development
Table YC Biotech (Jiangsu) Company Details
Table Xinxiang Tianfeng Fine Chemical Company Details
Table Global Mesalazine Sales Forecast by Regions 2019-2025 (MT)
Table Global Mesalazine Sales Market Share Forecast by Regions 2019-2025
Table Global Mesalazine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Mesalazine Revenue Market Share Forecast by Regions 2019-2025
Table Global Mesalazine Sales Forecast by Type 2019-2025 (MT)
Table Global Mesalazine Sales Market Share Forecast by Type 2019-2025
Table Global Mesalazine Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Mesalazine Revenue Market Share Forecast by Type 2019-2025
Table Global Mesalazine Sales Forecast by Application 2019-2025 (MT)
Table Global Mesalazine Sales Market Share Forecast by Application 2019-2025
Figure North America Mesalazine Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Mesalazine Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Mesalazine Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Mesalazine Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Mesalazine Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Mesalazine Value Chain
Table Mesalazine Customers List
Figure Channels of Distribution
Table Mesalazine Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs